Eterna Therapeutics Ownership 2024 | Who Owns Eterna Therapeutics Now?
Institutional Ownership
10.43%
Insider Ownership
39.31%
Retail Ownership
50.26%
Institutional Holders
18.00
Eterna Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
CYPRESS POINT WEALTH MANAGEMENT, LLC | 3.09% | 0.45% | 94,375 | - | - | 320,875,000 | Mar 31, 2023 |
NAVITER WEALTH, LLC | 2.61% | 0.09% | 79,666 | 45 | 0.06% | 270,864,000 | Mar 31, 2023 |
CI PRIVATE WEALTH, LLC | 2.01% | 0.00% | 61,189 | - | - | 214,071,000 | Mar 31, 2023 |
BLACKROCK INC. | 0.77% | - | 23,363 | 222 | 0.96% | 79,434,000 | Mar 31, 2023 |
VANGUARD GROUP INC | 0.63% | - | 19,068 | -10,000 | -34.40% | 64,831,000 | Mar 31, 2023 |
GEODE CAPITAL MANAGEMENT, LLC | 0.46% | - | 13,985 | - | - | 48,947,000 | Mar 31, 2023 |
RENAISSANCE TECHNOLOGIES LLC | 0.43% | 0.00% | 13,053 | -4,483 | -25.56% | 44,000 | Mar 31, 2023 |
BALDWIN BROTHERS LLC/MA | 0.31% | 0.00% | 9,470 | 278 | 3.02% | 32,198,000 | Mar 31, 2023 |
UBS GROUP AG | 0.13% | - | 3,864 | 3,864 | 100.00% | 13,138,000 | Mar 31, 2023 |
CARMICHAEL HILL & ASSOCIATES, INC. | 0.00% | 0.00% | 75 | - | - | 255,000 | Mar 31, 2023 |
MONTAG A & ASSOCIATES INC | 0.00% | - | 70 | - | - | 238,000 | Mar 31, 2023 |
MORGAN STANLEY | 0.00% | - | 50 | -1,313 | -96.33% | 170,000 | Mar 31, 2023 |
GROUP ONE TRADING, L.P. | 0.00% | - | 19 | - | - | 67,000 | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | 0.00% | - | 16 | -10 | -38.46% | 54,000 | Mar 31, 2023 |
CITIGROUP INC | 0.00% | - | 15 | - | - | 53,000 | Mar 31, 2023 |
ASPIRE PRIVATE CAPITAL, LLC | 0.00% | - | 10 | - | - | 34,000 | Mar 31, 2023 |
BANK OF AMERICA CORP /DE/ | 0.00% | - | 9 | - | - | 31,000 | Mar 31, 2023 |
FMR LLC | - | - | 1 | - | - | 4,000 | Mar 31, 2023 |
CREDIT SUISSE AG/ | - | - | - | -120 | -100.00% | - | Mar 31, 2023 |
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
CYPRESS POINT WEALTH MANAGEMENT, LLC | 3.09% | 0.45% | 94,375 | - | - | 320,875,000 | Mar 31, 2023 |
NAVITER WEALTH, LLC | 2.61% | 0.09% | 79,666 | 45 | 0.06% | 270,864,000 | Mar 31, 2023 |
BALDWIN BROTHERS LLC/MA | 0.31% | 0.00% | 9,470 | 278 | 3.02% | 32,198,000 | Mar 31, 2023 |
CI PRIVATE WEALTH, LLC | 2.01% | 0.00% | 61,189 | - | - | 214,071,000 | Mar 31, 2023 |
CARMICHAEL HILL & ASSOCIATES, INC. | 0.00% | 0.00% | 75 | - | - | 255,000 | Mar 31, 2023 |
RENAISSANCE TECHNOLOGIES LLC | 0.43% | 0.00% | 13,053 | -4,483 | -25.56% | 44,000 | Mar 31, 2023 |
MONTAG A & ASSOCIATES INC | 0.00% | - | 70 | - | - | 238,000 | Mar 31, 2023 |
ASPIRE PRIVATE CAPITAL, LLC | 0.00% | - | 10 | - | - | 34,000 | Mar 31, 2023 |
GEODE CAPITAL MANAGEMENT, LLC | 0.46% | - | 13,985 | - | - | 48,947,000 | Mar 31, 2023 |
UBS GROUP AG | 0.13% | - | 3,864 | 3,864 | 100.00% | 13,138,000 | Mar 31, 2023 |
BLACKROCK INC. | 0.77% | - | 23,363 | 222 | 0.96% | 79,434,000 | Mar 31, 2023 |
VANGUARD GROUP INC | 0.63% | - | 19,068 | -10,000 | -34.40% | 64,831,000 | Mar 31, 2023 |
GROUP ONE TRADING, L.P. | 0.00% | - | 19 | - | - | 67,000 | Mar 31, 2023 |
CITIGROUP INC | 0.00% | - | 15 | - | - | 53,000 | Mar 31, 2023 |
MORGAN STANLEY | 0.00% | - | 50 | -1,313 | -96.33% | 170,000 | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | 0.00% | - | 16 | -10 | -38.46% | 54,000 | Mar 31, 2023 |
BANK OF AMERICA CORP /DE/ | 0.00% | - | 9 | - | - | 31,000 | Mar 31, 2023 |
FMR LLC | - | - | 1 | - | - | 4,000 | Mar 31, 2023 |
CREDIT SUISSE AG/ | - | - | - | -120 | -100.00% | - | Mar 31, 2023 |
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
UBS GROUP AG | 0.13% | - | 3,864 | 3,864 | 100.00% | 13,138,000 | Mar 31, 2023 |
BALDWIN BROTHERS LLC/MA | 0.31% | 0.00% | 9,470 | 278 | 3.02% | 32,198,000 | Mar 31, 2023 |
BLACKROCK INC. | 0.77% | - | 23,363 | 222 | 0.96% | 79,434,000 | Mar 31, 2023 |
NAVITER WEALTH, LLC | 2.61% | 0.09% | 79,666 | 45 | 0.06% | 270,864,000 | Mar 31, 2023 |
FMR LLC | - | - | 1 | - | - | 4,000 | Mar 31, 2023 |
BANK OF AMERICA CORP /DE/ | 0.00% | - | 9 | - | - | 31,000 | Mar 31, 2023 |
CITIGROUP INC | 0.00% | - | 15 | - | - | 53,000 | Mar 31, 2023 |
GROUP ONE TRADING, L.P. | 0.00% | - | 19 | - | - | 67,000 | Mar 31, 2023 |
GEODE CAPITAL MANAGEMENT, LLC | 0.46% | - | 13,985 | - | - | 48,947,000 | Mar 31, 2023 |
ASPIRE PRIVATE CAPITAL, LLC | 0.00% | - | 10 | - | - | 34,000 | Mar 31, 2023 |
MONTAG A & ASSOCIATES INC | 0.00% | - | 70 | - | - | 238,000 | Mar 31, 2023 |
CARMICHAEL HILL & ASSOCIATES, INC. | 0.00% | 0.00% | 75 | - | - | 255,000 | Mar 31, 2023 |
CI PRIVATE WEALTH, LLC | 2.01% | 0.00% | 61,189 | - | - | 214,071,000 | Mar 31, 2023 |
CYPRESS POINT WEALTH MANAGEMENT, LLC | 3.09% | 0.45% | 94,375 | - | - | 320,875,000 | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | 0.00% | - | 16 | -10 | -38.46% | 54,000 | Mar 31, 2023 |
CREDIT SUISSE AG/ | - | - | - | -120 | -100.00% | - | Mar 31, 2023 |
MORGAN STANLEY | 0.00% | - | 50 | -1,313 | -96.33% | 170,000 | Mar 31, 2023 |
RENAISSANCE TECHNOLOGIES LLC | 0.43% | 0.00% | 13,053 | -4,483 | -25.56% | 44,000 | Mar 31, 2023 |
VANGUARD GROUP INC | 0.63% | - | 19,068 | -10,000 | -34.40% | 64,831,000 | Mar 31, 2023 |
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
VANGUARD GROUP INC | 0.63% | - | 19,068 | -10,000 | -34.40% | 64,831,000 | Mar 31, 2023 |
RENAISSANCE TECHNOLOGIES LLC | 0.43% | 0.00% | 13,053 | -4,483 | -25.56% | 44,000 | Mar 31, 2023 |
MORGAN STANLEY | 0.00% | - | 50 | -1,313 | -96.33% | 170,000 | Mar 31, 2023 |
CREDIT SUISSE AG/ | - | - | - | -120 | -100.00% | - | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | 0.00% | - | 16 | -10 | -38.46% | 54,000 | Mar 31, 2023 |
CYPRESS POINT WEALTH MANAGEMENT, LLC | 3.09% | 0.45% | 94,375 | - | - | 320,875,000 | Mar 31, 2023 |
CI PRIVATE WEALTH, LLC | 2.01% | 0.00% | 61,189 | - | - | 214,071,000 | Mar 31, 2023 |
CARMICHAEL HILL & ASSOCIATES, INC. | 0.00% | 0.00% | 75 | - | - | 255,000 | Mar 31, 2023 |
MONTAG A & ASSOCIATES INC | 0.00% | - | 70 | - | - | 238,000 | Mar 31, 2023 |
ASPIRE PRIVATE CAPITAL, LLC | 0.00% | - | 10 | - | - | 34,000 | Mar 31, 2023 |
GEODE CAPITAL MANAGEMENT, LLC | 0.46% | - | 13,985 | - | - | 48,947,000 | Mar 31, 2023 |
GROUP ONE TRADING, L.P. | 0.00% | - | 19 | - | - | 67,000 | Mar 31, 2023 |
CITIGROUP INC | 0.00% | - | 15 | - | - | 53,000 | Mar 31, 2023 |
BANK OF AMERICA CORP /DE/ | 0.00% | - | 9 | - | - | 31,000 | Mar 31, 2023 |
FMR LLC | - | - | 1 | - | - | 4,000 | Mar 31, 2023 |
NAVITER WEALTH, LLC | 2.61% | 0.09% | 79,666 | 45 | 0.06% | 270,864,000 | Mar 31, 2023 |
BLACKROCK INC. | 0.77% | - | 23,363 | 222 | 0.96% | 79,434,000 | Mar 31, 2023 |
BALDWIN BROTHERS LLC/MA | 0.31% | 0.00% | 9,470 | 278 | 3.02% | 32,198,000 | Mar 31, 2023 |
UBS GROUP AG | 0.13% | - | 3,864 | 3,864 | 100.00% | 13,138,000 | Mar 31, 2023 |
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
UBS GROUP AG | 0.13% | - | 3,864 | 3,864 | 100.00% | 13,138,000 | Mar 31, 2023 |
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
CREDIT SUISSE AG/ | - | - | - | -120 | -100.00% | - | Mar 31, 2023 |
Eterna Therapeutics Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
FIDELITY CONCORD STREET TRUST | 0.00% | 21,727 | -75 | -0.34% | Feb 29, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 26,099 | -26,099 | -50.00% | Mar 31, 2024 |
DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 5,904 | - | - | Jan 31, 2024 |
Guggenheim Active Allocation Fund | 0.00% | 8 | - | - | Feb 29, 2024 |
PROSHARES TRUST | 0.00% | 247 | - | - | Feb 29, 2024 |
EQ ADVISORS TRUST | 0.00% | 476 | - | - | Mar 31, 2024 |
Invesco Exchange-Traded Fund Trust II | 0.00% | 57 | - | - | Jan 31, 2024 |
Eterna Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
31 Mar, 23 | 18 | - |
31 Dec, 22 | 18 | - |
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
31 Mar, 23 | 318,298 | -3.49% |
31 Dec, 22 | 329,815 | - |
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
31 Mar, 23 | 10.43% | -6.97% |
31 Dec, 22 | 11.21% | - |
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
31 Mar, 23 | 3 | - |
31 Dec, 22 | - | - |
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
31 Mar, 23 | 4 | - |
31 Dec, 22 | - | - |
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
31 Mar, 23 | 18 | - | 318,298 | -3.49% | 10.43% | -6.97% | 3 | - | 4 | - |
31 Dec, 22 | 18 | - | 329,815 | - | 11.21% | - | - | - | - | - |
Eterna Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
Eterna Therapeutics Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q1 2024 | 2 | - | - |
Q4 2023 | 9 | 2 | 450.00% |
Q3 2023 | 8 | - | - |
Q2 2023 | 1 | 4 | 25.00% |
Q1 2023 | 1 | - | - |
Q4 2022 | - | 1 | - |
Q3 2022 | 1 | 1 | 100.00% |
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q1 2024 | - | - | - |
Q4 2023 | 6 | - | - |
Q3 2023 | 8 | - | - |
Q2 2023 | - | - | - |
Q1 2023 | - | - | - |
Q4 2022 | - | - | - |
Q3 2022 | - | - | - |
Eterna Therapeutics Peer Ownership
Ticker | Company |
---|---|
ZVSA | ZyVersa Therapeutics, Inc. |
XFOR | X4 Pharmaceuticals, Inc. |
CGEM | Cullinan Oncology, Inc. |
VECT | VectivBio Holding AG |
TCRX | TScan Therapeutics, Inc. |
APLS | Apellis Pharmaceuticals, Inc. |
RCUS | Arcus Biosciences, Inc. |
DAWN | Day One Biopharmaceuticals, Inc. |
PHIO | Phio Pharmaceuticals Corp. |
REVB | Revelation Biosciences, Inc. |
RLAY | Relay Therapeutics, Inc. |
RNAZ | TransCode Therapeutics, Inc. |
INZY | Inozyme Pharma, Inc. |
ANNX | Annexon, Inc. |
IMMX | Immix Biopharma, Inc. |
ABOS | Acumen Pharmaceuticals, Inc. |
ITOS | iTeos Therapeutics, Inc. |
GPCR | Structure Therapeutics Inc. |
UNCY | Unicycive Therapeutics, Inc. |
ZURA | Zura Bio Limited |
PALI | Palisade Bio, Inc. |
ERNA Ownership FAQ
Who Owns Eterna Therapeutics?
Eterna Therapeutics is owned by institutional shareholders (10.43%), insiders (39.31%), and public (50.26%). The largest institutional shareholder of Eterna Therapeutics is CYPRESS POINT WEALTH MANAGEMENT, LLC (3.09% of total shares) and the top mutual fund owner is FIDELITY CONCORD STREET TRUST (0.00% of total shares).
Who are the major institutional shareholders of Eterna Therapeutics?
Eterna Therapeutics's major institutional shareholders are CYPRESS POINT WEALTH MANAGEMENT, LLC, NAVITER WEALTH, LLC, CI PRIVATE WEALTH, LLC, BLACKROCK INC., and VANGUARD GROUP INC. The top five shareholders own together 9.10% of the company's share outstanding.
How many Eterna Therapeutics shareholders are there?
As of Mar 2023, there are 18 institutional shareholders of Eterna Therapeutics.
What percentage of Eterna Therapeutics is owned by CYPRESS POINT WEALTH MANAGEMENT, LLC?
CYPRESS POINT WEALTH MANAGEMENT, LLC owns 94.38K shares of Eterna Therapeutics, representing 3.09% of the company's total shares outstanding, valued at $320.88M (as of Mar 2023).
What percentage of Eterna Therapeutics is owned by NAVITER WEALTH, LLC?
As of Mar 2023, NAVITER WEALTH, LLC holds 79.67K shares of Eterna Therapeutics (ERNA), compromising 2.61% of the company, valued at $270.86M.
What percentage of Eterna Therapeutics is owned by CI PRIVATE WEALTH, LLC?
CI PRIVATE WEALTH, LLC is the third largest holder of Eterna Therapeutics. The company owns 61.19K of the company's shares outstanding (worth $214.07M).